These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 23593750

  • 21. Epilepsy is not a mandatory feature of STXBP1 associated ataxia-tremor-retardation syndrome.
    Gburek-Augustat J, Beck-Woedl S, Tzschach A, Bauer P, Schoening M, Riess A.
    Eur J Paediatr Neurol; 2016 Jul; 20(4):661-5. PubMed ID: 27184330
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P, Li Kan, Maytal J.
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities.
    Deb S, Kaur Saini ST.
    J Intellect Disabil Res; 2007 Jul; 51(Pt 7):564-5. PubMed ID: 17537170
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy.
    Grosso S, Franzoni E, Coppola G, Iannetti P, Verrotti A, Cordelli DM, Marchiani V, Pascotto A, Spalice A, Acampora B, Morgese G, Balestri P.
    Seizure; 2005 Jun; 14(4):248-53. PubMed ID: 15911359
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Excellent response to levetiracetam in epilepsy with Wolf-Hirschhorn syndrome.
    Karalok ZS, Arhan EP, Erdogan KM, Gurkas E.
    Childs Nerv Syst; 2016 Jan; 32(1):9-11. PubMed ID: 26590026
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intellectual disability without epilepsy associated with STXBP1 disruption.
    Hamdan FF, Gauthier J, Dobrzeniecka S, Lortie A, Mottron L, Vanasse M, D'Anjou G, Lacaille JC, Rouleau GA, Michaud JL.
    Eur J Hum Genet; 2011 May; 19(5):607-9. PubMed ID: 21364700
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Levetiracetam in refractory pediatric epilepsy.
    Wheless JW, Ng YT.
    J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Long-term accidental overdose of levetiracetam in an infant.
    Özkale Y, Özkale M, Saygi S, Erol I.
    J Child Neurol; 2014 Jul; 29(7):959-61. PubMed ID: 23520362
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The adult motor phenotype of Dravet syndrome is associated with mutation of the STXBP1 gene and responds well to cannabidiol treatment.
    Álvarez Bravo G, Yusta Izquierdo A.
    Seizure; 2018 Aug; 60():68-70. PubMed ID: 29929108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.